199 related articles for article (PubMed ID: 28807740)
1. Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas.
Crabtree Ramírez B; Caro Vega Y; Shepherd BE; Le C; Turner M; Frola C; Grinsztejn B; Cortes C; Padgett D; Sterling TR; McGowan CC; Person A
Int J Infect Dis; 2017 Oct; 63():57-63. PubMed ID: 28807740
[TBL] [Abstract][Full Text] [Related]
2. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
[TBL] [Abstract][Full Text] [Related]
3. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ
J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059
[TBL] [Abstract][Full Text] [Related]
4. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
Makadzange AT; Ndhlovu CE; Takarinda K; Reid M; Kurangwa M; Gona P; Hakim JG
Clin Infect Dis; 2010 Jun; 50(11):1532-8. PubMed ID: 20415574
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort study.
Crabtree-Ramírez BE; Caro-Vega Y; Belaunzarán-Zamudio PF; Shepherd BE; Rebeiro PF; Veloso V; Cortes CP; Padgett D; Gotuzzo E; Sierra-Madero J; McGowan CC; Person AK;
J Int AIDS Soc; 2019 Dec; 22(12):e25413. PubMed ID: 31855320
[TBL] [Abstract][Full Text] [Related]
6. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis.
Njei B; Kongnyuy EJ; Kumar S; Okwen MP; Sankar MJ; Mbuagbaw L
Cochrane Database Syst Rev; 2013 Feb; (2):CD009012. PubMed ID: 23450595
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
[TBL] [Abstract][Full Text] [Related]
8. Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America.
Cesar C; Koethe JR; Giganti MJ; Rebeiro P; Althoff KN; Napravnik S; Mayor A; Grinsztejn B; Wolff M; Padgett D; Sierra-Madero J; Gotuzzo E; Sterling TR; Willig J; Levison J; Kitahata M; Rodriguez-Barradas MC; Moore RD; McGowan C; Shepherd BE; Cahn P;
J Int AIDS Soc; 2016; 19(1):20684. PubMed ID: 26996992
[TBL] [Abstract][Full Text] [Related]
9. Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study.
Ingle SM; Miro JM; May MT; Cain LE; Schwimmer C; Zangerle R; Sambatakou H; Cazanave C; Reiss P; Brandes V; Bucher HC; Sabin C; Vidal F; Obel N; Mocroft A; Wittkop L; d'Arminio Monforte A; Torti C; Mussini C; Furrer H; Konopnicki D; Teira R; Saag MS; Crane HM; Moore RD; Jacobson JM; Mathews WC; Geng E; Eron JJ; Althoff KN; Kroch A; Lang R; Gill MJ; Sterne JAC
Clin Infect Dis; 2023 Jul; 77(1):64-73. PubMed ID: 36883578
[TBL] [Abstract][Full Text] [Related]
10. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.
Smiley CL; Rebeiro PF; Cesar C; Belaunzaran-Zamudio PF; Crabtree-Ramirez B; Padgett D; Gotuzzo E; Cortes CP; Pape J; Veloso VG; McGowan CC; Castilho JL;
Lancet HIV; 2021 May; 8(5):e266-e273. PubMed ID: 33891877
[TBL] [Abstract][Full Text] [Related]
11. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
13. Survival time of HIV-infected patients with cryptococcal meningitis.
Chottanapund S; Singhasivanon P; Kaewkungwal J; Chamroonswasdi K; Manosuthi W
J Med Assoc Thai; 2007 Oct; 90(10):2104-11. PubMed ID: 18041430
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of AIDS-associated cryptomeningitis.
Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America.
Castilho JL; Kim A; Jenkins CA; Grinsztejn B; Gotuzzo E; Fink V; Padgett D; Belaunzaran-Zamudio PF; Crabtree-Ramírez B; Escuder MM; Souza RA; Tenore SB; Pimentel SR; Ikeda MLR; de Alencastro PR; Tupinanbas U; Brites C; Luz E; Netto J; Cortes CP; Grangeiro A; Shepherd BE; McGowan CC;
J Int AIDS Soc; 2021 Jan; 24(1):e25658. PubMed ID: 33405281
[TBL] [Abstract][Full Text] [Related]
16. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
Bisson GP; Molefi M; Bellamy S; Thakur R; Steenhoff A; Tamuhla N; Rantleru T; Tsimako I; Gluckman S; Ravimohan S; Weissman D; Tebas P
Clin Infect Dis; 2013 Apr; 56(8):1165-73. PubMed ID: 23362285
[TBL] [Abstract][Full Text] [Related]
17. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
[TBL] [Abstract][Full Text] [Related]
18. Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda.
Namutebi AM; Kamya MR; Byakika-Kibwika P
Afr Health Sci; 2013 Dec; 13(4):977-85. PubMed ID: 24940321
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
[TBL] [Abstract][Full Text] [Related]
20. MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA.
Baldassarre R; Mdodo R; Omonge E; Jaoko W; Baddley J; Pappas P; Aban I; Odera S; Suleh A; Jolly PE
East Afr Med J; 2014 May; 91(5):145-51. PubMed ID: 25684784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
